Home / People / Angelika Wieczorkowski
Portrait ofAngelika Wieczorkowski

Angelika Wieczorkowski, LL.M.

Senior Associate

CMS Hasche Sigle
Theodor-Heuss-Straße 29
70174 Stuttgart
Germany
Languages German, English, Polish

Angelika Wieczorkowski specialises in German, EU competition and merger control law, with a focus on the coordination, management and implementation of e-discovery projects in administrative fine proceedings and antitrust audits. Her advisory practice also covers antitrust due diligence in the context of M&A transactions. Angelika also advises on merger control proceedings, including the coordination of multijurisdictional merger control proceedings. She offers companies guidance and support in the event of Dawn Raids conducted by competition authorities and is a member of the CMS Dawn Raid Team in Stuttgart.

Angelika joined CMS in 2013 as a qualified Wirtschaftsjurist (German business lawyer degree). Prior to that, she trained with CMS from 2002 to 2005 as Rechtsanwalts- und Notarfachangestellte (qualified lawyer's and notary's assistant) and worked in that capacity as a legal assistant at CMS until 2013.

more less

Relevant experience

  • Internationally operating company | Advice on and assistance with the coordination and implementation of an internal audit regarding potential antitrust violations
  • Trader of chemist’s goods | Coordination, management and implementation of e-discovery process in cartel fine proceedings
  • SYNLAB | Merger control law advice on the acquisition of ALcontrol
  • Schuler AG | Merger control law advice on the acquisition of Farina Presse
  • Scholz Recycling | Merger control law advice on the acquisition by Chiho-Tiande
  • DMG MORI | Merger control law advice on the sale of shares in DMG Mori Finance
  • Jason Industries | Merger control law advice on the acquisition of Dronco GmbH
more less

Memberships & Roles

  • Associated member of Studienvereinigung Kartellrecht e.V.
more less

Education

  • 2013 - 2015: Master's degree in commercial law from Hamburg University of Applied Sciences
  • 2009 - 2012: Bachelor's degree in commercial law from EuroFH University in Hamburg
  • 2002 - 2005: Training as lawyer's and notary's assistant at CMS
more less
12/05/2022
10 key aspects of the revised EU competition law in the field of distribution...
The new Vertical Block Exemption Regulation (VBER) and the new accompanying Vertical Guidelines (VGL) were published on 10 May 2022. The new VBER will enter into force on 1 June 2022 and apply for the next twelve years. The new VBER/VGL introduce sev

Feed

21/02/2024
CMS advises MVZ Laaff on sale to amedes
Stuttgart – The founder of medical laboratory MVZ Laaff, Prof. Helmut Laaff, has sold MVZ Laaff GmbH with its facilities in Freiburg, Heilbronn and Ulm to the amedes Group. amedes is a leading German lab services provider, operating a number of healthcare centres throughout Germany with different specialisations. MVZ Laaff provides services in fields of medicine including derma­to­path­o­logy, general pathology, immunohistology, molecular pathology and cytology, and is one of the leading laboratories in these specialist areas. Details of the transaction were not disclosed.A CMS team headed by lead partner Dr Christoph Lächler advised Prof. Helmut Laaff on all legal aspects of the transaction. The sale took place by way of an auction process. A particular focus of the advice was on structuring the transaction and the associated regulatory issues. CMS Germany Dr Christoph Lächler, Lead Part­ner Stefan-Ul­rich Müller, Partner Dr Jacob Siebert, Partner Viktoria Barthel, Senior Associate Tobias Kalski, Senior As­so­ci­ate An­dreas Kazmaier, Associate, all Corporate/M&A Dr Roland Wiring, Partner Dr Siham Hidar, Senior Associate, both Regulatory Dr Harald Kahlenberg, Partner Angelika Wieczorkowski, Senior Associate, both Antitrust, Competition & Trade Dr Stefan Voss, Partner Lukas Potstada, Counsel, both Real Estate Dr Martin Mohr, Partner, TaxPress Con­tact presse@cms-hs. com
06/12/2023
CMS advises Hamelin on merger control proceedings - German Cartel Office...
Stuttgart - The German Federal Cartel Office (Bundes­kar­tellamt) has cleared the acquisition of the German stationery manufacturer Pelikan by the French group Hamelin. The merger control proceedings involved...
14/08/2023
CMS advises SYNLAB on sale of Veterinary Diagnostics business to Mars
Stuttgart – The SYNLAB Group, a leading provider of medical diagnostic services and specialist tests in Europe, has sold its Veterinary Diagnostics business (SYNLAB VET) to a subsidiary of US group...
05/09/2022
CMS advises Clariant on the Signing of definitive agreement to sell Quats...
Stuttgart – Clariant, a focused, sustainable, and innovative specialty chemical company, announced that it has reached a definitive agreement for the divestment of its Quats business to Global Amines...
20/01/2022
Success for Federal State of Baden-Württem­berg in “timber dispute” before...
Stuttgart – On 20 January 2022, Stuttgart Regional Court dismissed the lawsuit brought by 36 sawmills against the Federal State of Baden-Württem­berg in what has been dubbed the “timber dispute”...
20/05/2021
CMS advises Discovery Life Sciences on acquisition of Targos Molecular...
Berlin - US-based biospecimen and biomarker specialist Discovery Life Sciences has acquired Targos Molecular Pathology GmbH. The acquisition of one of the largest molecular pathology laboratories in Europe...
30/12/2020
CMS advises savings banks in Kaiserslautern on merger
Stuttgart – District savings bank Kreissparkasse Kaiserslautern is merging with its municipal counterpart Stadtsparkasse Kaiserslautern. This involves Stadtsparkasse Kaiserslautern being absorbed into...
18/12/2020
CMS advises Dürr on acquisition of majority stake in teamtechnik
Stuttgart – The Dürr Group has acquired 75% of the shares in teamtechnik Maschinen und Anlagen GmbH, thereby strengthening its market position in the automation sector. teamtechnik, which is headquartered...
10/12/2020
CMS advises shareholders in biotech company Labor Dr. Merk & Kollegen on...
Stuttgart – Pharmaceutical group Boehringer Ingelheim has signed an agreement to acquire all the shares in Germany-based biotech company Labor Dr. Merk & Kollegen. Boehringer Ingelheim intends to use...
11/09/2019
CMS advises shareholders in Panorama Fachkliniken on sale to Oberberg Group
Stuttgart – The owner-managed Panorama Fachkliniken hospitals in Scheidegg, southern Germany, have been successfully sold to the Oberberg Group. The shareholders in Panorama Fachkliniken decided to...
07/08/2019
Victory for ROSSMANN before Federal Court of Justice with aid of CMS
Stuttgart – At the beginning of 2018, Dirk Rossmann GmbH lodged an appeal at the Federal Court of Justice (BGH) against the ruling handed down by Düsseldorf Higher Regional Court (OLG) (Case Ref. V-4...
07/05/2019
CMS supports Bechtle on acquisition of IT specialists Bücker and Coffee
Stuttgart – CMS Germany has advised Bechtle AG on its acquisition of specialist firms R. Bücker EDV-Beratung Datentechnik GmbH and Coffee GmbH. A team headed by Dr Harald Kahlenberg advised the IT...